- £46.60m
- £43.10m
- £6.00m
Holding(s) in Company
Welsh Labour Leader visits Creo’s facilities
Holding(s) in Company
LTIP Awards
Holding(s) in Company
Microwave Lung Ablation Update
Brief: Creo Medical Expects To Report Growth In Group Revenues Of 13% To £30.8m In FY23
Trading Update
Strategic Collaboration with Khalifa University
Speedboat® UltraSlim roll-out reaches Asia Pacific
Award of Shares under Share Incentive Plan
First use of Speedboat® UltraSlim in Latin America
First use of Speedboat® UltraSlim in the USA
First European Speedboat® UltraSlim procedure
Brief: Creo Medical Group Receives US FDA Clearance For Its Speedboat Ultraslim Device
Speedboat® UltraSlim: US FDA Clearance
Brief: Creo Medical Group Says Speedboat Ultraslim EU Launch Accelerated By 18 Months
Investor Presentation
Brief: Creo Medical Group Posts H1 Gross Profit 7.5 Million Stg